MedTrace Logo

A Novel Nomogram to Predict Severity of COVID-19

NCT04366024 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-02-23

No results posted yet for this study

Summary

Investigators use clinical data from a large sample of COVID-19 disease patients to screen out biomarkers associated with disease severity. Then, a novel nomogram model will be established to predict covid-19 disease severity, which could provide important assistance and supplement for clinical work. In the case of extremely shortage of front-line medical resources, patients with potential severe diseases will be timely treated with the help of the novel nomogram model.

Conditions

  • COVID-19 Disease
  • Nomogram Model

Interventions

OTHER

other

clinical diagnosis

Sponsors & Collaborators

  • Xinqiao Hospital of Chongqing

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-17
Primary Completion
2020-08-30
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04366024 on ClinicalTrials.gov